2011
DOI: 10.4081/cp.2011.e126
|View full text |Cite
|
Sign up to set email alerts
|

Partial Splenic Embolization for Refractory Thrombocytopenia

Abstract: When the platelet count falls below 20×109/L, the risk of spontaneous life threatening hemorrhage is concerning for both physician and patient. When medical management fails, splenectomy is often used to manage the severe thrombocytopenia before spontaneous, life-threatening gastrointestinal or intracranial bleeding occurs. We present the non surgical management of such a patient with refractory sever thrombocytopenia who refused surgical intervention. She underwent partial splenic embolic therapy with 500–700… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 7 publications
0
2
0
Order By: Relevance
“…In addition, SE has been successfully applied to treat refractoriness to RBC transfusion secondary to hypersplenism, potentially predicting the utility of subsequent splenectomy 66–68 . Furthermore, though not included in the analysis of effectiveness, we identified 11 citations that described the successful use of SE in young and adult patients with ITP who were considered unsuitable candidates for splenectomy, 16,17,41,42,44,69–72 declined surgery 73 or individuals who experienced ITP relapse post‐splenectomy due to accessory spleen 74,75 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, SE has been successfully applied to treat refractoriness to RBC transfusion secondary to hypersplenism, potentially predicting the utility of subsequent splenectomy 66–68 . Furthermore, though not included in the analysis of effectiveness, we identified 11 citations that described the successful use of SE in young and adult patients with ITP who were considered unsuitable candidates for splenectomy, 16,17,41,42,44,69–72 declined surgery 73 or individuals who experienced ITP relapse post‐splenectomy due to accessory spleen 74,75 …”
Section: Discussionmentioning
confidence: 99%
“…[22][23][24][25][26][27][28][29][30][31][32][33]65 In addition, SE has been successfully applied to treat refractoriness to RBC transfusion secondary to hypersplenism, potentially predicting the utility of subsequent splenectomy. [66][67][68] Furthermore, though not included in the analysis of effectiveness, we identified 11 citations that described the successful use of SE in young and adult patients with ITP who were considered unsuitable candidates for splenectomy, 16,17,41,42,44,[69][70][71][72] declined surgery 73 or individuals who experienced ITP relapse post-splenectomy due to accessory spleen. 74,75 Like SE, splenic irradiation has also been extensively described as a viable alternative to splenectomy in patients with massive splenomegaly leading to debilitating symptoms with severe cytopenias, and who are not suitable candidates for surgery.…”
Section: Study Year (Reference)mentioning
confidence: 99%